Evidence map›Paper›PMID 33344469›Full record

ArticleFrontiers in medicine2020

Patterns of Deterioration in Moderate Patients With COVID-19 From Jan 2020 to Mar 2020: A Multi-Center, Retrospective Cohort Study in China.

Sheng-Long Chen, Hui-Ying Feng, Hui Xu, Shan-Shan Huang, Jiu-Feng Sun, Lin Zhou, Jun-Lei He, Wen-Liang Song, Rui-Jie Wang, Xin Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Infectious Complications After Tocilizumab in Patients with COVID: A Real-World Experience.Journal of community hospital internal medicine perspectives · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Dexamethasone in COVID-19: Should we consider a "golden hour" practice?International journal of clinical practice · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Sheng-Long ChenGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Hui-Ying FengCenter for Tuberculosis Control of Guangdong Province, Guangzhou, China.
Hui XuGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Shan-Shan HuangCenter for Tuberculosis Control of Guangdong Province, Guangzhou, China.
Jiu-Feng SunGuangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou, China.
Lin ZhouCenter for Tuberculosis Control of Guangdong Province, Guangzhou, China.
Jun-Lei HeCenter for Tuberculosis Control of Guangdong Province, Guangzhou, China.
Wen-Liang SongGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Rui-Jie WangGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Xin LiGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ming FangGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Center for Tuberculosis Control of Guangdong Province · CNGuangdong Academy of Medical Sciences · CNGuangdong Provincial People's Hospital · CNGuangdong Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19deteriorationmoderatepatterntime point

Identifiers

PMID33344469
PMCPMC7744800
OpenAlexW3106782249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.